Mission First: Pharma Should Partner, Not Build, Their AI Solutions

^{Published on 2025-03-31 11:02:35 - Forbes}

In pharma, buying software (instead of building) means working with industry professionals who can develop solutions to meet their needs
even before they realize they have them.

The article from Forbes Technology Council, published on March 31, 2025, discusses the strategic approach pharmaceutical companies should take towards AI integration. It argues that rather than building their own AI solutions, pharma companies should partner with established AI technology providers. The key points include the complexity and cost of developing AI in-house, the rapid evolution of AI technology which requires constant updates, and the benefits of leveraging external expertise. Partnering allows pharma companies to focus on their core mission of drug discovery and development while utilizing AI to enhance efficiency, reduce costs, and accelerate innovation. The article highlights that such partnerships can provide access to cutting-edge AI tools, reduce the risk of technological obsolescence, and foster innovation through collaborative efforts, ultimately leading to better patient outcomes and more efficient drug development processes.

Read the Full Forbes Article at:
[ https://www.forbes.com/councils/forbestechcouncil/2025/03/31/mission-first-pharma-should-partner-not-build-their-ai-solutions/ ]

N@N

Mission First: Pharma Should Partner, Not Build, Their AI Solutions